NIELSEN HOLDINGS PLC (NLSN)       27.98  +0.01 (+0.04%)

27.98  +0.01 (+0.04%)

GB00BWFY5505 - Common Stock - After market: 27.99 +0.01 (+0.04%)


Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to NLSN. NLSN was compared to 70 industry peers in the Professional Services industry. Both the profitability and the financial health of NLSN get a neutral evaluation. Nothing too spectacular is happening here. NLSN is valued expensive and it does not seem to be growing.




Profitability

Profitability Rating

4

NLSN has a Profit Margin of 14.99%. This is amongst the best returns in the industry. The industry average is 6.71%. NLSN outperforms 89% of its industry peers.
NLSN's Return On Assets of 4.86% is in line with the rest of the industry. The industry average Return On Assets is 5.21%.

NLSN has a Piotroski-F score of 6.00. This indicates an average health and profitability for NLSN.
NLSN's Return On Equity of 15.26% is worse than the rest of the industry. The industry average Return On Equity is 18.47%.
VS Industry

ROA (4.86%) VS Industry: 48% outperformed.

-415.60
46.57

ROE (15.26%) VS Industry: 35% outperformed.

0.52
249.34

Profit Margin (14.99%) VS Industry: 89% outperformed.

0.20
37.19

Valuation

Valuation Rating

3

The Price/Earnings Ratio is 15.37, which indicates a correct valuation of NLSN.
Compared to an average industry Price/Earning Ratio of 16.40, NLSN is valued in line with its industry peers.
The Forward Price/Earnings Ratio of 13.98 indicates a correct valuation of NLSN.
With a price book ratio of 2.90, NLSN is valued correctly.

When comparing the price book ratio of NLSN to the average industry price book ratio of 2.41, NLSN is valued in line with its industry peers.
Compared to an average industry Enterprise Value to EBITDA ratio of 12.63, NLSN is valued in line with its industry peers.
The high PEG Ratio, which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
VS Industry

Price/Earnings (15.37) VS Industry: 54% outperformed.

1,210.50
1.98

Price/Book (2.9) VS Industry: 43% outperformed.

72.71
0.04

Enterprise Value/ EBITDA (11.18) VS Industry: 55% outperformed.

48.62
0.29

Growth

Growth Rating

3

The EPS growth is accelerating: in the next 5 years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last 5 years to the growth rate of the upcoming 5 years, we see that the growth is accelerating.
The earnings per share for NLSN have decreased by -2.15% in the last year.
The Earnings Per Share has been decreasing by -6.84% on average over the past 5 years.

NLSN is expected to show a small growth in Earnings Per Share. In the coming 5 years, the EPS will grow by 5.62% yearly.
The Revenue is expected to grow by 3.21% on average over the next 5 years.
The Revenue for NLSN has decreased by -28.72% in the past year. This is quite bad
Measured over the past 5 years, NLSN shows a very negative growth in Revenue. The Revenue has been decreasing by -11.12% on average per year.

PastFuture
5Y3Y1Y1Y2Y3Y5Y
EPS-6.84% 23.97% -2.15% 6.17% 5.15% 6.05% 5.62%
Revenue-11.12% -18.71% -28.72% 2.38% 3.15% 3.41% 3.21%

Health

Health Rating

4

NLSN has a Current Ratio of 2.04. This indicates that NLSN is financially healthy and has no problem in meeting its short term obligations.
When comparing the Current Ratio to an average industry Current Ratio of 1.43, NLSN is better placed than the average industry peer to meet its short term obligations.
NLSN has a Quick Ratio of 2.04. This indicates that NLSN is financially healthy and has no problem in meeting its short term obligations.
The Quick Ratio of NLSN is much better than the industry average of 1.43.

The Piotroski-F score of NLSN is 6.00. This is a neutral score and indicates average health and profitability for NLSN.
Compared to an average industry Debt to Equity Ratio of 0.35, NLSN is requires more financing than its industry peers. 94% of its industry peers have a better Debt to Equity Ratio.
Based on the Altman-Z score of 1.46, we must say that NLSN is in the distress zone and has some risk of bankruptcy.
When comparing the Altman-Z score of NLSN to the average industry Altman-Z score of 3.17, NLSN is less financially healthy than its industry peers.
VS Industry

Debt/Equity (1.61) VS Industry: 6% outperformed.

6.11
0.00

Quick Ratio (2.04) VS Industry: 71% outperformed.

0.17
15.36

Current Ratio (2.04) VS Industry: 71% outperformed.

0.17
15.36

Altman-Z (1.46) VS Industry: 22% outperformed.

-47.05
45.17

Dividend

Dividend Rating

3

NLSN pays out 16.23% of its income as dividend. This is a sustainable payout ratio.
NLSN has been paying a dividend for over 5 years, so it has already some track record.
With a yearly dividend of 0.86%, NLSN is not a good candidate for dividend investing.

Compared to an average industry Dividend Yield of 1.48, NLSN's dividend is way lower than its industry peers. On top of this 80% of the companies listed in the same industry pay a better dividend than NLSN!
Compared to an average S&P500 Dividend Yield of 2.43, NLSN's dividend is way lower than the S&P500 average.
The dividend of NLSN decreases each year by -44.32%.
VS Industry

Dividend Yield (0.86%) VS Industry: 20% outperformed.

0.50
4.51
NLSN Daily chart

NIELSEN HOLDINGS PLC27.98

NYSE:NLSN (10/11/2022, 7:25:24 PM)+0.01 (+0.04%)

After market: 27.99 +0.01 (+0.04%)

Chartmill FA Rating
GICS Sector Industrials
GICS IndustryGroup Commercial & Professional Services
GICS Industry Professional Services
Earnings (Last) 07-27 2022-07-27/bmo Earnings (Next) 11-04 2022-11-04/bmo
Ins Owners 0.01% Inst Owners 98.37%
Market Cap 10.07B Analysts 71.43
Valuation
PE 15.37 Fwd PE 13.98
PEG (NY) 2.49 PEG (5Y) N/A
P/S 2.85 P/B 2.9
EV/EBITDA 11.18
Dividend
Dividend Yield 0.86% Dividend Growth -44.32%
DP 16.23% Ex-Date 08-17 2022-08-17 (0.06)
Growth
EPS 1Y -2.15% EPS 3Y 23.97%
EPS 5Y -6.84% EPS growth Q2Q 6.98%
EPS Next Y 6.17% EPS Next 2Y 5.15%
EPS Next 3Y 6.05% EPS Next 5Y 5.62%
Revenue growth 1Y -28.72% Revenue growth 3Y -18.71%
Revenue growth 5Y -11.12% Revenue growth Q2Q 2.44%
Revenue Next Year 2.38% Revenue Next 2Y 3.15%
Revenue Next 3Y 3.41% Revenue Next 5Y 3.21%
Health
Current Ratio 2.04 Quick Ratio 2.04
Altman-Z 1.46 F-Score 6
Debt/Equity 1.61 WACC 7.27%
ROIC/WACC 7.09
Profitability
ROA 4.86% ROE 15.26%
ROICexgc 51.61% ROIC 6.42%
PM 14.99% OM 23.51%
Asset Turnover 0.32

Fundamental Stock Screener Links

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA